Literature DB >> 9727983

Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment.

S B Levy.   

Abstract

Mesh：

Year:  1998        PMID： 9727983      PMCID： PMC1113828          DOI： 10.1136/bmj.317.7159.612

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci.

Authors:  M C Moken; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

2.  Multidrug resistance--a sign of the times.

Authors:  S B Levy
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

3.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

4.  Vancomycin resistance in staphylococci.

Authors:  K Hiramatsu
Journal:  Drug Resist Updat       Date:  1998       Impact factor: 18.500

5.  Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.

Authors:  M Oethinger; I Podglajen; W V Kern; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191
  5 in total
  10 in total

Review 1.  Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana?

Authors:  B Cookson
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

Review 2.  Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance.

Authors:  Peter Gilbert; Andrew J McBain
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 3.  Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.

Authors:  Heather E Elphick; Alison Scott
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

4.  Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.

Authors:  Mohan Pammi; Steven A Abrams
Journal:  Cochrane Database Syst Rev       Date:  2019-05-11

Review 5.  Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.

Authors:  Mohan Pammi; Gautham Suresh
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

Review 6.  Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia.

Authors:  Mohan Pammi; Peter Brocklehurst
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 7.  Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.

Authors:  Lil Breen; Nivedita Aswani
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

8.  Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.

Authors:  Mohan Pammi; Gautham Suresh
Journal:  Cochrane Database Syst Rev       Date:  2020-03-31

9.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

10.  Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.

Authors:  Poppy Holland; Nikki Jahnke
Journal:  Cochrane Database Syst Rev       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.